Skip to content

Medical-device intelligence

GLZ: Antigens, If, Toxoplasma Gondii

FDA product code GLZ: Antigens, If, Toxoplasma Gondii. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
GLZ
FDA device name
Antigens, If, Toxoplasma Gondii
Device class
2
Regulation number
866.3780
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

18 clearance records and 0 recall records in the covered releases, across 13 source company names and 1 product codes. Dated history runs from Dec 22, 1977 to Mar 23, 1993.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
GLZ · Antigens, If, Toxoplasma Gondii180

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

18 matching records
Device / recordCompany in FDA recordSourceSource date
TOXOPLASMA IGM IFA TEST SYSTEMK924882 · GLZZeus Scientific, Inc.510(k)Mar 23, 1993FDA decision date
TOXO IGM TESTK880007 · GLZGull Laboratories, Inc.510(k)Mar 17, 1988FDA decision date
FIAX TOXO-M ANTIBODIES TEST KITK850591 · GLZIntl. Diagnostic Technology510(k)Apr 30, 1985FDA decision date
ADPIFA TEST FOR ANTIBODIES TO TOXOPLASMA GONDIIK844287 · GLZApple Diagnostic Products510(k)Jan 7, 1985FDA decision date
ANTI-TOXOPLASMA GONDII KITK842664 · GLZAmico Lab, Inc.510(k)Aug 28, 1984FDA decision date
IMMUNOENZYME TEST SYS-DETECT-IGM ANTIK832900 · GLZBionetic Laboratory Products510(k)Nov 14, 1983FDA decision date
POLYCHACO INDIRECT IMMUNOFLUORESCENCEK830869 · GLZParasitic Disease Consultants510(k)Aug 11, 1983FDA decision date
TOXOPLASMOSIS TEST KITK811562 · GLZImmuno-Diagnostic Products, Inc.510(k)Jul 16, 1981FDA decision date
TOXOPLASMA GONDII SEROLOGICAL REAGENTSK803134 · GLZMicrobiological Research Corp.510(k)Jan 29, 1981FDA decision date
TOXO BIO-BEAD TITRATION KITK801720 · GLZLitton Bionetics510(k)Sep 16, 1980FDA decision date
TOXO BIO-BEAD SCREEN KITK791611 · GLZLitton Bionetics510(k)Nov 13, 1979FDA decision date
TORCH BIO-BEAD SCREEN KITK791618 · GLZLitton Bionetics510(k)Nov 13, 1979FDA decision date
TOXOPLASMA ANTIBODY TEST SYSTEMK791571 · GLZZeus Scientific, Inc.510(k)Sep 24, 1979FDA decision date
FIAX TEST KIT FOR ANTI-TOXOPLASMA ANTIBOK790464 · GLZIntl. Diagnostic Technology510(k)Jun 13, 1979FDA decision date
QUANTAZYME TOXOPLASMAK790360 · GLZBio-Rad510(k)May 22, 1979FDA decision date
TOXELISA TEST KITK781549 · GLZMicrobiological Assoc.510(k)Dec 7, 1978FDA decision date
IMMUNOZYME TOXOPLASMA ANTIBODYK780352 · GLZMillipore Corp.510(k)Jun 28, 1978FDA decision date
TOXO TESTK772243 · GLZGull Laboratories, Inc.510(k)Dec 22, 1977FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗